Fenofibrate tablets USP, is a lipid regulating agent available as tablets for oral administration. Each tablet contains 54 mg or 160 mg of fenofibrate . The chemical name for fenofibrate is 2-[4-(4-chlorobenzoyl) phenoxy]-2-methyl-propanoic acid, 1-methylethyl ester with the following structural formula: The molecular formula is C 20 H 21 O 4 Cl and the molecular weight is 360.83; fenofibrate is insoluble in water. The melting point is 79-82°C. Fenofibrate is a white solid which is stable under ordinary conditions. Inactive Ingredients Each tablet contains Croscarmellose sodium, Crospovidone, Docusate sodium, Lecithin, Mannitol, Microcrystalline cellulose, Polyvinyl alcohol-part hydrolyzed, Povidone,Sodium lauryl Sulphate, Sodium stearyl fumarate, Talc, Titanium dioxide, Xanthan gum. In addition, 54 mg individual tablets contain: Iron oxide yellow FDA approved dissolution test specifications differ from USP. str

What kind of drug is fenofibrate?

The FDA classifies fenofibrate as a peroxisome proliferator receptor alpha agonist. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

Can you take fenofibrate with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run fenofibrate against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What brand names is fenofibrate sold under?

We track 8 fenofibrate-containing products in the U.S.: Fenofibrate (Micronized), Lipidil, Tricor, Tricor (Micronized), Fenofibrate, Fenoglide, Lipofen and Triglide. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

What forms does fenofibrate come in?

Across the brands we track, fenofibrate is currently marketed as capsule and tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic fenofibrate?

Yes. Our catalog lists 2 generic fenofibrate products alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Has fenofibrate been recalled?

The FDA's Enforcement database lists 2 recall records whose product description mentions fenofibrate. The most recent: Fenofibrate Capsules (May 28, 2026). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Fenofibrate: uses, dosing, side effects & brands

Fenofibrate is a peroxisome proliferator receptor alpha agonist sold in the U.S. under 8 brand and generic names, for coronary artery disease, hypercholesterolemia and hyperlipoproteinemias. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesHow we research

Key facts

Drug class: Peroxisome Proliferator Receptor Alpha Agonist
Treats: Coronary Artery Disease, Hypercholesterolemia and Hyperlipoproteinemias
Available as: Capsule · Tablet
Sold as: 8 products — Fenofibrate (Micronized), Lipidil and Tricor, and others
Prescription?: Prescription only
Generic available?: Yes
Typical price: about $4 for a 30-count supply

How fenofibrate is dosed

From the FDA label for Fenofibrate (Micronized) (application ANDA207564). Other fenofibrate products — different forms, different strengths — are dosed differently. Follow the label for the one you were prescribed.

2 DOSAGE & ADMINISTRATION • Primary hypercholesterolemia or mixed dyslipidemia: Initial dose of 160 mg once daily ( 2.2 ). • Severe hypertriglyceridemia: Initial dose of 54 to 160 mg once daily. Maximum dose is 160 mg ( 2.3 ). • Renally impaired patients: Initial dose of 54 mg once daily ( 2.4 ). • Geriatric patients: Select the dose on the basis of renal function ( 2.5 ). • Should be given with meals ( 2.1 ). 2.1 General Considerations Patients should be placed on an appropriate lipid-lowering diet before receiving fenofibrate tablets, and should continue this diet during treatment with fenofibrate tablets. Fenofibrate tablets should be given with meals, thereby optimizing the bioavailability of the medication. The initial treatment for dyslipidemia is dietary therapy specific for the type of lipoprotein abnormality. Excess body weight and excess alcoholic intake may be important factors in hypertriglyceridemia and should be addressed prior to any drug therapy. Physical exercise can be an important ancillary measure. Diseases contributory to hyperlipidemia, such as hypothyroidism or diabetes mellitus should be looked for and adequately treated. Estrogen therapy, thiazide diuretics and beta-blockers, are sometimes associated with massive rises in plasma triglycerides, especially in subjects with familial hypertriglyceridemia. In such cases, discontinuation of the specific…

Fenofibrate side effects

The following serious adverse reactions are described below and elsewhere in the labeling: • Mortality and coronary heart disease morbidity [see Warnings and Precautions ( 5.1 ) ] • Hepatotoxicity [see Warnings and Precautions ( 5.2) ] • Pancreatitis [ see Warnings and Precautions ( 5.7 ) ] • Hypersensitivity reactions [ see Warnings and Precautions ( 5.9 ) ] • Venothromboembolic disease [ see Warnings and Precautions ( 5.10) ] Adverse reactions > 2% and at least 1% greater than placebo: Abnormal liver tests, increased AST, increased ALT, increased CPK, and rhinitis ( 6 ). To report SUSPECTED ADVERSE REACTIONS, contact Macleods Pharma USA, Inc. at 1-888-943-3210 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. Adverse events reported by 2% or more of patients treated with fenofibrate (and greater than placebo) during the double-blind, placebo-controlled trials, regardless of causality, are listed in Table 1 below. Adverse events led to discontinuation of treatment in 5.0% of patients treated with fenofibrate and in 3.0% treated with placebo. Increases in liver function tests were…

Every fenofibrate product we track (8)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Fenofibrate products
#	Drug	Rating	Type	Form	Generic?	Typical price
1	Fenofibrate (Micronized)	72/100	Prescription	Capsule	Generic	$4	View →
2	Lipidil	70/100	Prescription	Capsule	Generic

What fenofibrate pills look like

Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.

Fenofibrate pill imprints
Imprint	Strength	Colour	Shape	Maker
LS;215	160 mg	white	oval	—
RG78	43 mg	white	capsule	—
RG79	130 mg	white	capsule	—
FN2	160 mg	white	oval	—
A319	200 mg	orange	capsule	—
93;7330	54 mg	yellow

Fenofibrate recalls

From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.

Frequently asked questions

What is fenofibrate?: Fenofibrate tablets USP, is a lipid regulating agent available as tablets for oral administration. Each tablet contains 54 mg or 160 mg of fenofibrate . The chemical name for fenofibrate is 2-[4-(4-chlorobenzoyl) phenoxy]-2-methyl-propanoic acid, 1-methylethyl ester with the following structural formula: The molecular formula is C 20 H 21 O 4 Cl and the molecular weight is 360.83; fenofibrate is insoluble in water. The melting point is 79-82°C. Fenofibrate is a white solid which is stable under ordinary conditions. Inactive Ingredients Each tablet contains Croscarmellose sodium, Crospovidone, Docusate sodium, Lecithin, Mannitol, Microcrystalline cellulose, Polyvinyl alcohol-part hydrolyzed, Povidone,Sodium lauryl Sulphate, Sodium stearyl fumarate, Talc, Titanium dioxide, Xanthan gum. In addition, 54 mg individual tablets contain: Iron oxide yellow FDA approved dissolution test specifications differ from USP. str
What kind of drug is fenofibrate?: The FDA classifies fenofibrate as a peroxisome proliferator receptor alpha agonist. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.
Can you take fenofibrate with other medicines?: It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run fenofibrate against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is fenofibrate sold under?: We track 8 fenofibrate-containing products in the U.S.: Fenofibrate (Micronized), Lipidil, Tricor, Tricor (Micronized), Fenofibrate, Fenoglide, Lipofen and Triglide. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does fenofibrate come in?: Across the brands we track, fenofibrate is currently marketed as capsule and tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.